John Paulson Paulson & Co
John Paulson is the founder of Paulson & Co., a firm that became world-famous for profits related to the 2007–2008 housing and credit crisis. Beyond that landmark trade, the firm has pursued merger arbitrage, event-driven, and opportunistic credit and equity strategies. Paulson remains one of the most recognized names in modern hedge fund history.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$88.1M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$36.7M |
| 3 |
Qiagen
QGEN
|
+$23.7M |
| 4 |
Equinox Gold
EQX
|
+$22.4M |
| 5 |
TCO
Taubman Centers Inc.
TCO
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngloGold Ashanti
AU
|
+$108M |
| 2 |
AGN
Allergan plc
AGN
|
+$107M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$85.4M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$54.7M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$45.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.82% |
| 2 | Materials | 23.67% |
| 3 | Communication Services | 9.93% |
| 4 | Financials | 9.1% |
| 5 | Consumer Discretionary | 2.35% |
Similar funds
John Paulson's Q2 2020 Portfolio in Review
As of Q2 2020, John Paulson held 37 positions worth $3.13B, up 19% from $2.62B the previous quarter. Its ten largest holdings account for 79% of the portfolio.
John Paulson withdrew a net $424M in Q2 2020, closing 7 positions and reducing 10 holdings. Its most notable exit was Allergan plc, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 44% a quarter earlier, followed by Materials and Communication Services.
Against the trend, John Paulson opened a new position in TD Ameritrade Holding Corp worth $35.5M.
- John Paulson's largest Q2 2020 buy was TD Ameritrade Holding Corp: 975,000 shares worth $35.5M.
- John Paulson added most to Bausch Health in Q2 2020, an estimated $88.1M increase.
- John Paulson's biggest Q2 2020 reduction was AngloGold Ashanti, cutting an estimated $108M.
- John Paulson fully exited Allergan plc in Q2 2020, selling an estimated $107M.
- John Paulson's ten largest holdings make up 79% of its $3.13B portfolio in Q2 2020.
- John Paulson opened 4 new positions and closed 7 in Q2 2020.
- John Paulson's portfolio value rose 19% quarter-over-quarter to $3.13B.
Based on Paulson & Co's 13F filing for Q2 2020, filed 14 Aug 2020.